Comparative Clinical Study To Evaluate The Effect of Sarpagandha Ghana Vati and Kusmanda Rasayan After Medical Purgation in Management of Hypertension.
Not Applicable
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2022/02/039948
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Systolic blood pressure >140 mm Hg
Diastolic blood pressure >90 mm Hg
Fit for Purgation therapy
Willing to consent
Exclusion Criteria
Systolic >180 mm Hg, Diastolic >100 mm Hg
Secondary Hypertension (CKD, Endocrine disorder, Type I , Type II diabetic ,pregnancy induced hypertension
Age below 21 and above 70
Unfit for virechana
Hypersensitivity to trail drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate and to compare the therapeutic effect of Sarpagandha Ghana Vati and Kushmanda Rasayana in the management of Vyanabala Vaishamya(Essential Hypertension).Timepoint: 106 days
- Secondary Outcome Measures
Name Time Method Change in quality of life SF-36 quality of life.Timepoint: 106 days;Change in symptoms of Vyanabala Vaishamya (Essential Hypertension)Timepoint: 106 days